We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+0.56%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$100B
AUM Growth
-$9.45B
Cap. Flow
-$5.83B
Cap. Flow %
-5.81%
Top 10 Hldgs %
31.76%
Holding
3,811
New
911
Increased
1,180
Reduced
974
Closed
681

Top Sells

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$4.21B
2
VOO icon
Vanguard S&P 500 ETF
VOO
+$2.87B
3
WMT icon
Walmart Inc
WMT
+$831M
4
AMZN icon
Amazon
AMZN
+$692M
5
LLY icon
Eli Lilly
LLY
+$641M

Sector Composition

Rank Sector Weight
1 Technology 19.57%
2 Consumer Discretionary 11.57%
3 Healthcare 9.79%
4 Financials 6.87%
5 Industrials 5.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WDAY icon
2976
PUT
Workday
WDAY
$33.3B
$39K ﹤0.01%
+300
New +$47.6K
TXN icon
2977
CALL
Texas Instruments
TXN
$257B
$38.8K ﹤0.01%
+200
New +$40.5K
EVO icon
2978
Evotec
EVO
$693M
$38K ﹤0.01%
15,189
+2,266
+18% +$7.3K
LYFT icon
2979
CALL
Lyft
LYFT
$5.53B
$37.2K ﹤0.01%
2,800
MGX icon
2980
Metagenomi Therapeutics
MGX
$45.6M
$36.9K ﹤0.01%
27,521
-51,615
-65% -$80.2K
AUTL
2981
Autolus Therapeutics
AUTL
$391M
$36.8K ﹤0.01%
26,682
-243,595
-90% -$370K
AFRM icon
2982
CALL
Affirm
AFRM
$23.7B
$36.7K ﹤0.01%
800
+600
+300% +$34.7K
SHAK icon
2983
CALL
Shake Shack
SHAK
$2.27B
$35.4K ﹤0.01%
400
+100
+33% +$9.2K
AMGN icon
2984
PUT
Amgen
AMGN
$203B
$35.2K ﹤0.01%
+100
New +$35.6K
VEEV icon
2985
PUT
Veeva Systems
VEEV
$30.2B
$35.1K ﹤0.01%
200
RPID icon
2986
Rapid Micro Biosystems
RPID
$99.1M
$34.6K ﹤0.01%
15,224
-47,687
-76% -$175K
AMT icon
2987
CALL
American Tower
AMT
$78B
$34.5K ﹤0.01%
200
GD icon
2988
PUT
General Dynamics
GD
$104B
$34.3K ﹤0.01%
100
DOW icon
2989
CALL
Dow Inc
DOW
$21.6B
$33.3K ﹤0.01%
800
+700
+700% +$22.2K
BEKE icon
2990
PUT
KE Holdings
BEKE
$16.9B
$32.9K ﹤0.01%
+2,200
New +$37.8K
FXE icon
2991
PUT
Invesco CurrencyShares Euro Currency Trust
FXE
$331M
$32K ﹤0.01%
300
-5,000
-94% -$540K
PATH icon
2992
PUT
UiPath
PATH
$5.61B
$31.1K ﹤0.01%
2,800
-24,200
-90% -$308K
LULU icon
2993
PUT
lululemon athletica
LULU
$13B
$30.6K ﹤0.01%
200
-500
-71% -$89.6K
HLT icon
2994
CALL
Hilton Worldwide
HLT
$74.3B
$30.4K ﹤0.01%
100
-100
-50% -$30.3K
AR icon
2995
CALL
Antero Resources
AR
$11B
$29.7K ﹤0.01%
+700
New +$25.5K
ATI icon
2996
PUT
ATI
ATI
$27.3B
$29.1K ﹤0.01%
+200
New +$27.9K
HYFT
2997
MindWalk Holdings
HYFT
$61.2M
$28.5K ﹤0.01%
25,246
-105,820
-81% -$168K
ROKU icon
2998
CALL
Roku
ROKU
$21.1B
$28.4K ﹤0.01%
+300
New +$29.2K
SKIN icon
2999
SkinHealth Systems
SKIN
$96.4M
$28.2K ﹤0.01%
+31,679
New +$38.9K
AMPG icon
3000
AmpliTech
AMPG
$139M
$27.4K ﹤0.01%
14,442
-46,167
-76% -$136K

Similar funds

Marshall Wace's Q1 2026 Portfolio in Review

As of Q1 2026, Marshall Wace held 3,811 positions worth $100B, down 8.6% from $110B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Marshall Wace withdrew a net $5.83B in Q1 2026, closing 681 positions and reducing 974 holdings. Its most notable exit was Vanguard S&P 500 ETF, an estimated $2.87B position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Marshall Wace opened a new position in State Street SPDR Portfolio S&P 500 ETF worth $3.8B.

  • Marshall Wace's largest Q1 2026 buy was State Street SPDR Portfolio S&P 500 ETF: 49,650,246 shares worth $3.8B.
  • Marshall Wace added most to Chevron in Q1 2026, an estimated $527M increase.
  • Marshall Wace's biggest Q1 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $4.21B.
  • Marshall Wace fully exited Vanguard S&P 500 ETF in Q1 2026, selling an estimated $2.87B.
  • Marshall Wace's ten largest holdings make up 32% of its $100B portfolio in Q1 2026.
  • Marshall Wace opened 911 new positions and closed 681 in Q1 2026.
  • Marshall Wace's portfolio value fell 8.6% quarter-over-quarter to $100B.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.